Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
for
Generalized Anxiety Disorder
Location: Decatur GA, Birmingham AL, Flowood MS, Tampa FL,
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 18+
Code: NCT06701903
Phase 2, Recruiting
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
for
Alzheimer Disease
Location: Decatur GA, Durham NC, The Villages FL, Maitland FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 50 - 70+
Code: NCT06297590
Phase 1, Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: Atlanta GA, Greenville SC, Birmingham AL, Knoxville TN,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase 3, Recruiting
Use of Repris Needle in Bladder Injection
for
Overactive Bladder Syndrome
Location: Cartersville GA
Sponsor: Uro-1 Medical
Sex: Female
Age: 18+
Code: NCT04982120
Recruiting
Pompe Pregnancy Sub-Registry
for
Glycogen Storage Disease Type II (GSD-II),
Location: Atlanta GA, Greenville SC, Jacksonville FL, Durham NC,
Sponsor: Genzyme, a Sanofi Company
Sex: Female
Age: 0+
Code: NCT00567073
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Location: Atlanta GA, Birmingham AL, Columbia SC, Nashville TN,
Sponsor: Medtronic
Sex: All
Age: 0+
Code: NCT00271180
Recruiting
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
for
Focal Segmental Glomerulosclerosis
Location: East Point GA, Chattanooga TN, Huntsville AL,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 12+
Code: NCT07220083
Phase 3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Atlanta GA, Chattanooga TN, Greenville SC, Augusta GA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase 3, Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
for
Major Depressive Disorder (MDD),
Location: Decatur GA, Atlanta GA, Jacksonville FL, Orlando FL,
Sponsor: Seaport Therapeutics
Sex: All
Age: 18 - 65
Code: NCT07065240
Phase 2, Recruiting
Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 Infection
for
HIV/AIDS
Location: Decatur GA, Orlando FL, Saint Louis MO,
Sponsor: Frontier Biotechnologies Inc.
Sex: All
Age: 18+
Code: NCT04560569
Phase 2, Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
for
Schizophrenia
Location: Decatur GA, Atlanta GA, Little Rock AR, Gaithersburg MD,
Sponsor: Reviva Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT05184335
Phase 3, Recruiting
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy